These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 17875778

  • 1. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
    Zheng X, Cui XX, Avila GE, Huang MT, Liu Y, Patel J, Kong AN, Paulino R, Shih WJ, Lin Y, Rabson AB, Reddy BS, Conney AH.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5480-7. PubMed ID: 17875778
    [Abstract] [Full Text] [Related]

  • 2. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.
    Zheng X, Chang RL, Cui XX, Avila GE, Hebbar V, Garzotto M, Shih WJ, Lin Y, Lu SE, Rabson AB, Kong AN, Conney AH.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3444-51. PubMed ID: 16740769
    [Abstract] [Full Text] [Related]

  • 3. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
    Swamy MV, Patlolla JM, Steele VE, Kopelovich L, Reddy BS, Rao CV.
    Cancer Res; 2006 Jul 15; 66(14):7370-7. PubMed ID: 16849589
    [Abstract] [Full Text] [Related]

  • 4. Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence.
    Zheng X, Cui XX, Gao Z, Zhao Y, Lin Y, Shih WJ, Huang MT, Liu Y, Rabson A, Reddy B, Yang CS, Conney AH.
    Cancer Prev Res (Phila); 2010 Jan 15; 3(1):114-24. PubMed ID: 20051379
    [Abstract] [Full Text] [Related]

  • 5. A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.
    Ding N, Cui XX, Gao Z, Huang H, Wei X, Du Z, Lin Y, Shih WJ, Rabson AB, Conney AH, Hu C, Zheng X.
    Int J Oncol; 2014 Jun 15; 44(6):2139-45. PubMed ID: 24647860
    [Abstract] [Full Text] [Related]

  • 6. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
    Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M, Mukhtar H.
    Clin Cancer Res; 2007 Mar 01; 13(5):1611-9. PubMed ID: 17332308
    [Abstract] [Full Text] [Related]

  • 7. Celecoxib combined with atorvastatin prevents progression of atherosclerosis.
    Raval M, Frank PG, Laury-Kleintop L, Yan G, Lanza-Jacoby S.
    J Surg Res; 2010 Oct 01; 163(2):e113-22. PubMed ID: 20538289
    [Abstract] [Full Text] [Related]

  • 8. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.
    Narayanan NK, Narayanan BA, Reddy BS.
    Int J Oncol; 2005 Mar 01; 26(3):785-92. PubMed ID: 15703837
    [Abstract] [Full Text] [Related]

  • 9. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
    Reddy BS, Wang CX, Kong AN, Khor TO, Zheng X, Steele VE, Kopelovich L, Rao CV.
    Cancer Res; 2006 Apr 15; 66(8):4542-6. PubMed ID: 16618783
    [Abstract] [Full Text] [Related]

  • 10. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA, Narayanan NK, Pittman B, Reddy BS.
    Clin Cancer Res; 2004 Nov 15; 10(22):7727-37. PubMed ID: 15570007
    [Abstract] [Full Text] [Related]

  • 11. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice.
    Khor TO, Keum YS, Lin W, Kim JH, Hu R, Shen G, Xu C, Gopalakrishnan A, Reddy B, Zheng X, Conney AH, Kong AN.
    Cancer Res; 2006 Jan 15; 66(2):613-21. PubMed ID: 16423986
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells.
    Qin J, Yuan J, Li L, Liu H, Qin R, Qin W, Chen B, Wang H, Wu K.
    Biomed Pharmacother; 2009 Mar 15; 63(3):241-8. PubMed ID: 18617357
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.
    Wang H, Cui XX, Goodin S, Ding N, Van Doren J, Du Z, Huang MT, Liu Y, Cheng X, Dipaola RS, Conney AH, Zheng X.
    Oncol Rep; 2014 Feb 15; 31(2):835-41. PubMed ID: 24296978
    [Abstract] [Full Text] [Related]

  • 14. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ.
    Clin Cancer Res; 2005 Mar 01; 11(5):1999-2007. PubMed ID: 15756026
    [Abstract] [Full Text] [Related]

  • 15. Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice.
    Yonou H, Kanomata N, Goya M, Kamijo T, Yokose T, Hasebe T, Nagai K, Hatano T, Ogawa Y, Ochiai A.
    Cancer Res; 2003 May 01; 63(9):2096-102. PubMed ID: 12727825
    [Abstract] [Full Text] [Related]

  • 16. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
    Narayanan BA, Reddy BS, Bosland MC, Nargi D, Horton L, Randolph C, Narayanan NK.
    Clin Cancer Res; 2007 Oct 01; 13(19):5965-73. PubMed ID: 17908994
    [Abstract] [Full Text] [Related]

  • 17. [The growth inhibitory effect of non-steroid anti-inflammatory drugs on ovarian cancer].
    Wang HJ, Peng ZL, Liu XQ, Yang KX, Lou JY, Luo FM.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun 01; 38(3):428-32. PubMed ID: 17593823
    [Abstract] [Full Text] [Related]

  • 18. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
    Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT.
    Cancer; 2007 Feb 01; 109(3):588-97. PubMed ID: 17177201
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect.
    Sievers EM, Bart RD, Backhus LM, Lin Y, Starnes M, Castanos R, Starnes VA, Bremner RM.
    J Thorac Cardiovasc Surg; 2005 Jun 01; 129(6):1242-9. PubMed ID: 15942563
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA, Krebiehl G, Dittmann K, Kehlbach R, Rodemann HP.
    Radiother Oncol; 2007 Feb 01; 82(2):229-38. PubMed ID: 17207548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.